The Inflammation Pathway from Cholesterol to Aging

Description

For the first time, in five hundred years since Spanish explorer Juan Ponce de Leon discovered Florida while searching for the Fountain of Youth, an inflammatory pathway has been identified as the key to Aging and the diseases associated with Aging.

Cholesterol and the Production of Cholesterol by the Liver leads to activation of a specific Inflammation Pathway that has been identified by Dr Sota Omoigui. This Inflammation Pathway has been identified after extensive research of the medical literature, as the key trigger for Aging and many disorders associated with Aging including Heart Disease, Stroke, Skin Wrinkles, Type 2 Diabetes, Dementia, Alzheimer’s Disease, Osteoporosis, Arthritis and certain types of Cancers.

Prescription medications such as Statins act on a small branch of this pathway but yet have led to a significant decrease in mortality and morbidity from Heart Disease, Stroke, Type 2 Diabetes and Dementia. Statins reduce the incidence of Arthritis and certain types of Cancers and can increase bone density and treat osteoporosis by acting on this same pathway.

Dr Sota Omoigui in a major breakthrough has identified the exact way that statins and bisphosphonate medications block a minor branch of this inflammatory pathway. Even more significant, Dr Sota Omoigui has identified key plant compounds that are available today and described a road map for new drugs that can block this inflammation pathway far more effectively than any Statin medication available today. These plant compounds and new drugs will stop the aging process and fulfill the thousand years quest by mankind to discover the fountain of youth.

This book and Sota Omoigui’s Law of Aging will endure as a significant milestone in the age-old quest of mankind to conquer aging and disorders of aging.